RxDoctor Payments Data

Harris Waheed, MD

Family Medicine · Kankakee, ILNPI 1164511580

Payments from drug & device makers

$13,537in general payments, 2019–2025

Across 789 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Nestle Healthcare Nutrition Inc.$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$939
  • plus $6K from 36 others

What the payments were for

  • Food & beverage$13,486100%
  • Education$510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,537 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$85,133
Medicare patients
158
Services billed
1,059

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin148$99,037
OzempicSemaglutide50$66,468
FarxigaDapagliflozin Propanediol71$46,606
ZenpepLipase/Protease/Amylase16$45,044
TrulicityDulaglutide21$21,250
JanuviaSitagliptin Phosphate14$20,386
RybelsusSemaglutide18$17,488
TradjentaLinagliptin13$13,482
XareltoRivaroxaban15$11,919
EliquisApixaban15$10,651
DuleraMometasone/Formoterol22$7,720
Tresiba Flextouch U-100Insulin Degludec17$7,412
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$3,174
Albuterol Sulfate HfaAlbuterol Sulfate114$3,082
AvalideIrbesartan/Hydrochlorothiazide11$3,031

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$939$112,519161 claims
Novo NordiskOzempic, Rybelsus$1,057$83,95668 claims
AstraZenecaFarxiga$1,709$46,60671 claims
Aimmune Therapeutics, Inc.Zenpep$835$45,04416 claims
MerckJanuvia, Dulera$275$28,10636 claims
Lilly USA, LLCTrulicity$1,102$21,25021 claims
Johnson & JohnsonXarelto$93$11,91915 claims
PfizerEliquis$162$10,65115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Kankakee

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →